Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors

被引：16
|
作者：
Gravani, A. [1 ]
Gaitanis, G. [1 ]
Tsironi, T. [1 ]
Tigas, S. [2 ]
Bassukas, I. D. [1 ]
机构：
[1] Univ Ioannina, Sch Hlth Sci, Dept Skin & Venereal Dis, Fac Med, Ioannina, Greece
[2] Univ Ioannina, Sch Hlth Sci, Dept Endocrinol, Fac Med, Ioannina, Greece
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 12期
关键词：
D O I：
10.1111/jdv.14957
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E438 / E439
页数：2
相关论文
共 50 条
  • [41] Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors
    Ozeki, Takeshi
    Muramatsu, Ken
    Yoshimoto, Norihiro
    Ujiie, Inkin
    Izumi, Kentaro
    Iwata, Hiroaki
    Mushiroda, Taisei
    Ujiie, Hideyuki
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : 2219 - +
  • [42] Defining dipeptidyl peptidase-4 inhibitors-related bullous pemphigoid: A single-centre retrospective study
    Maria Nieto-Benito, Lula
    Bergon-Sendin, Marta
    Pulido-Perez, Ana
    Manuel Rosell-Diaz, Angel
    Parra-Blanco, Veronica
    Suarez-Fernandez, Ricardo
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (09) : 1345 - 1351
  • [43] Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
    Fania, Luca
    Salemme, Adele
    Provini, Alessia
    Pagnanelli, Gianluca
    Collina, Maria Chiara
    Abeni, Damiano
    Didona, Biagio
    Di Zenzo, Giovanni
    Mazzanti, Cinzia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : 592 - 595
  • [44] Dipeptidyl Peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes: A population-based cohort study
    Douros, Antonios
    Rouette, Julie
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 225 - 226
  • [45] Bullous Drug Reaction with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
    Geetha, K.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2022, 13 (01) : 99 - 101
  • [46] Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
    Driessen, Johanna H. M.
    van Onzenoort, Hein A. W.
    Henry, Ronald M. A.
    Lalmohamed, Arief
    van den Bergh, Joop P.
    Neef, Cees
    Leufkens, Hubert G. M.
    de Vries, Frank
    BONE, 2014, 68 : 124 - 130
  • [47] Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
    Samoilova, Iuliia G.
    Vaizova, Olga E.
    Stankova, Anastasia E.
    Matveeva, Mariia, V
    Podchinenova, Daria, V
    Kudlay, Dmitry A.
    Borozinets, Anastasiia A.
    Filippova, Tatyana A.
    Grishkevich, Ivan R.
    Partala, Anastasia, V
    Gerasimova, Diana A.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (01): : 63 - 67
  • [48] Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Esaki, Hiroki
    Tachi, Tomoya
    Goto, Chitoshi
    Sugita, Ikuto
    Kanematsu, Yuta
    Yoshida, Aki
    Saito, Kosuke
    Noguchi, Yoshihiro
    Ohno, Yuki
    Aoyama, Satoshi
    Yasuda, Masahiro
    Mizui, Takashi
    Yamamura, Masumi
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [49] Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid diagnosed by oral manifestation
    Yanai, Yuta
    Kori, Yuriko
    Fujimoto, Tatsufumi
    Imajo, Ikumi
    Yanai, Risa
    Yamada, Tomohiro
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2023, 35 (06) : 528 - 533
  • [50] Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes
    Shi, Mai
    Yang, Aimin
    Chow, Elaine
    Lau, Eric S. H.
    Tam, Claudia H. T.
    Kong, Alice P. S.
    Luk, Andrea O. Y.
    Ma, Ronald C. W.
    Cheung, Christina M. T.
    Chan, Juliana C. N.
    Chan, Agnes W. S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E375 - E377
12345